ID
17589
Beschrijving
NCT00428090 / GSK-AVA105640 A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1) Any untoward medical occurence in a patient or clinical investigation subject, temporally associated with the use of a medicinal product, wether or not considered related to the medicinal product. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medicinal product. For marketed medicinal products, this also includes failure to produce expected benefits (i.e. lack of effiacy), abuse or misuse. Examples of an AE includes: - Significant or unexpected worsening or exacerbation of the condition/ indication under study. - Exacerbation of a chronic or intermittent pre-existing condition including either an increase in frequency and/or intensity of the condition. - New condition(s) detected or diagnosed after investigational product administration even though it may have been present prior to the start of the study. - Signs, symptoms, or the clinical sequelae of a suspected interaction. - Signs, symptoms, or the clinical sequelae of a suspected overdose of either investigational product or a concomitant medication (overdose per se should not be reported as an AE/SAE). Examples of an AE does NOT include a/an: - Medical or surgical procedure (e.g. endescopy, appendectomy); the condition that leads to the procedure is an AE. -Situations where an untoward medical occurence did not occur (social and/or convenience admission to a hospital). - Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present or detected at the start of the study that do not worsen. -The disease/disorder being studied, or expected progression, signs, or symptoms of the diseae/disorder being studied, unless more severe than expected for the subject's condition. For GSK clinical studies, AEs may include pre- or post-treatment events that occur as a result of protocol-mandated procedures (i.e., invasive procedures, modification of subject's previous therapeutic regimen). See protocol for clarification. If this event meets the definition of serious, complete the Serious Adverse Event Section.
Trefwoorden
Versies (2)
- 18-09-16 18-09-16 -
- 25-09-16 25-09-16 -
Geüploaded op
25 september 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC-ND 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
REFLECT-1 Non-Serious Adverse Events NCT00428090
REFLECT-1 Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
Beschrijving
Non-Serious Adverse Events (AE)
Alias
- UMLS CUI-1
- C1518404
Beschrijving
Non-Serious Adverse Event
Datatype
text
Alias
- UMLS CUI [1]
- C1518404
Beschrijving
Non-Serious Adverse Event Specification
Datatype
text
Alias
- UMLS CUI [1,1]
- C1518404
- UMLS CUI [1,2]
- C2348235
Beschrijving
Start Date
Datatype
date
Maateenheden
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C0808070
Beschrijving
Outcome
Datatype
integer
Alias
- UMLS CUI [1]
- C1705586
Beschrijving
End Date
Datatype
date
Maateenheden
- dd/MMM/yy
Alias
- UMLS CUI [1]
- C0806020
Beschrijving
Maximum Intensity
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0518690
- UMLS CUI [1,2]
- C0877248
Beschrijving
Action Taken with Investigational Product
Datatype
integer
Alias
- UMLS CUI [1]
- C1704758
Beschrijving
Withdrawal
Datatype
boolean
Alias
- UMLS CUI [1]
- C2349954
Beschrijving
Relationship to Investigational Product
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0085978
- UMLS CUI [1,2]
- C0877248
Similar models
REFLECT-1 Non-Serious Adverse Events NCT00428090
- StudyEvent: ODM
C2348235 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])